|Titre :||Preventing transitions into injection drug use: A call for gender-responsive upstream prevention (2020)|
|Auteurs :||S. A. MEYERS ; L. R. SMITH ; D. WERB|
|Type de document :||Article : Périodique|
|Dans :||International Journal of Drug Policy (Vol.83, September 2020)|
|Article en page(s) :||art. 102836|
|Discipline :||PRE (Prévention / Prevention)|
Thésaurus TOXIBASESEXE FEMININ ; PREVENTION ; INJECTION ; DIFFERENCE DE GENRE ; INTERVENTION ; ACCES AUX SOINS ; FACTEUR DE RISQUE
In 2017, there were large increases (260-500%) in overdose deaths among women in the United States across age groups (30-64 years and 55-64 years). In addition, U.S. women who inject drugs (WWID) are at increased risk for substance use-related disease transmission, bacterial infections, as well as sexual and physical violence compared to men who inject drugs. Relatedly, women face unique access barriers to substance use-related services, such as stigma and low coverage of gender-specific drug use-related services. Despite these heightened risks experienced by WWID, interventions specifically tailored to preventing women from transitioning into injection drug use have not been developed to date. As such, we advocate for the development of gender-responsive programs to prevent injection drug use initiation. This is critical to ensuring a comprehensive approach to preventing injection drug use initiation among those populations at highest risk of injection-related morbidity and mortality.
• Women who inject drugs are at increased risk of disease transmission and violence.
• Women also face unique barriers to accessing substance use-related services.
• Gender-responsive programs to prevent transitions into drug injecting are needed.
|Domaine :||Drogues illicites / Illicit drugs|
|Affiliation :||Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA|